When patients report palpitations during semaglutide therapy, a systematic approach to management balances symptom relief with continuation of beneficial treatment
10.1016/j.celrep.2014.04.037 143 NabeS.YamadaT.SuzukiJ.ToriyamaK.YasuokaT.KuwaharaM.et al (2018)
10.1038/s41420-019-0214-2 102 RaimondiV.CiottiG.GottardiM.CiccareseF
They also saw that Contrave reduced certain cardiometabolic risk factors, such as LDL cholesterol levels, fasting insulin levels, and waist circumference
Long-term semaglutide safety concerns are reasonable questionsmost clinical data spans 23 years, and post-market surveillance is ongoing
Current clinical guidelines from major organizations including the American Diabetes Association (ADA) and the American Gastroenterological Association (AGA) do not specifically address combining tirzepatide with orlistat, reflecting the absence of robust clinical trial data for this combination